THEMISMEDBSETHEMIS MEDICARE LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 28 Oct, 2026 · 20:01 IST

Promoter pledges 2.5 million shares for debentures

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹99.90
prior close
₹100.45
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Pharmaceuticals peers, median of 171sector+0.4%-2.4% vs sector

On the reaction day the stock moved 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-1.1
15m
-1.7
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.0pendingpending+0.4-2.4
Next day
———-0.6—
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Vividhmargi Investments pledged 2.5 million Themis Medicare shares on 27 October 2026 for unlisted, non-convertible debentures issued by OSS Software Solutions Labs. The pledge covers 2.71% of company capital, lifting total promoter-pledged shares to 7 million, or 7.60%. Shares were valued at Rs 23.8 crore against Rs 13.5 crore of borrowing, for promoter group personal use.

Likely market impact

The pledge adds collateral and possible future disposal risk. No sale or invocation was reported, and pledged promoter holdings remain only 7.60% of company capital.